Advertisement
Advertisement
Advertisement
Advertisement
“I have not been on drugs to lose weight!” says Kyle Richards

“I have not been on drugs to lose weight!” says Kyle Richards

“I have not been on drugs to lose weight!” says Kyle Richards

“I have not been on drugs to lose weight!” says Kyle Richards

Advertisement
  • Kyle Richards said she hasn’t used anything to reduce her weight.
  • She was accused of taking Ozempic a drug used to treat type 2 diabetes.
  • She wrote: “I am NOT on ozempic. Never have been.”
Advertisement

The 54-year-old reality actress was accused of taking Ozempic, a drug used to treat type 2 diabetes, after posting a workout video on Instagram. However, she quickly responded to the accusations, insisting she had “never” used any kind of weight-loss medication.

She wrote: “I am NOT on ozempic. Never have been. I am NOT taking Ozempic. Never have”(sic)

After which, one fan speculated that the ‘The Real Housewives of Beverly Hills’ star had been overindulging in plastic surgery, but Kyle once again shut down the comments by stating that the only recent form of cosmetic surgery she had was a breast reduction and insisting she is always “honest” with her fans about what she chooses to do.

The follower wrote: “I think it’s many visits to the plastic surgeon”

Kyle replied: “I have never tried Ozempic and this is not from plastic surgery. I did have a breast reduction in May. I’m honest about what I do. But if giving plastic surgery the credit makes you feel better then pop off sister,” with a kissing-face emoji.”

Also Read

Kyle Richards slams Reza Farahan for labeling her as most overrated Housewife
Kyle Richards slams Reza Farahan for labeling her as most overrated Housewife

Kyle Richards slams Reza Farahan for labelling her as the most overrated...

Advertisement
Advertisement
Read More News On

Catch all the Entertainment News, Hollywood News, Breaking News Event and Latest News Updates on The BOL News


Download The BOL News App to get the Daily News Update & Follow us on Google News.


End of Article

Next Story